Effect of oral treatment with the glycosaminoglycan sulodexide on peritoneal transport in CAPD patients.
Fracasso
Agostino
A
Division of Nephrology, Umberto I General Hospital, Mestre-Venice, Italy. agostino.fracasso@ulss12.ve.it
Baggio
Bruno
B
Masiero
Mauro
M
Bonfante
Luciana
L
Bazzato
Giorgio
G
Feriani
Mariano
M
Gambaro
Giovanni
G
D000284:Administration, Oral; D000368:Aged; D004305:Dose-Response Relationship, Drug; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006025:Glycosaminoglycans / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010537:Peritoneum / Q000187:drug effects* / Q000378:metabolism*; D010539:Permeability
D005343:Fibrinolytic Agents; D006025:Glycosaminoglycans; C007858:glucuronyl glucosamine glycan sulfate